Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
5 clinical trials · Condition
◉ Watch Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
| Record | Firm | Date |
|---|---|---|
| Long-Chain Fatty Acid Oxidation Disorders Online Disease Monitoring Program (NCT04812106) | Ultragenyx Pharmaceutical Inc | 2022-07-25 |
| Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program (NCT04632953) | Ultragenyx Pharmaceutical Inc | 2021-11-30 |
| Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program (NCT03768817) | Ultragenyx Pharmaceutical Inc | 2019-01-30 |
| A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) (NCT01886378) | Ultragenyx Pharmaceutical Inc | 2014-02-06 |
Track Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) automatically
Every clearance here is in the API, with alerts when new ones post.